Shares of Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) were up 0.5% on Wednesday . The stock traded as high as $6.14 and last traded at $6.08. Approximately 5,532 shares were traded during mid-day trading, a decline of 25% from the average daily volume of 7,393 shares. The stock had previously closed at $6.05.
Fortress Biotech Price Performance
The business has a 50 day moving average price of $6.64 and a 200-day moving average price of $6.13.
About Fortress Biotech
Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.
Further Reading
- Five stocks we like better than Fortress Biotech
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Buffett’s on the Sidelines – Should You Follow?
- 3 Tickers Leading a Meme Stock Revival
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
